The production of red blood cell alloantibodies in mice transfused with blood from transgenic Fyb-expressing mice

Transfusion

Volumn 46, Issue 10, 2006, Pages 1682-1688

  Campbell Lee, Sally A ^a   Liu, Jinhuan ^b   Velliquette, Randall W ^b   Halverson, Gregory R ^b   Shirey, R Sue ^b   Chaudhuri, Asok ^b   Reid, Marion E ^b   Ness, Paul M ^b   Baldwin, William M ^b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; BLOOD GROUP ANTIGEN; BLOOD GROUP DUFFY 3 ANTIGEN; BLOOD GROUP DUFFY 6 ANTIGEN; BLOOD GROUP DUFFY ANTIGEN; BLOOD GROUP DUFFY B ANTIGEN; ERYTHROCYTE ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; UNCLASSIFIED DRUG;

ALLOIMMUNIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; BLOOD TRANSFUSION; CELL SURVIVAL; CONTROLLED STUDY; ERYTHROCYTE; FLOW CYTOMETRY; MOUSE; NONHUMAN; SENSITIZATION; SERUM; TRANSGENIC MOUSE;

ANIMALS; ANTIBODY FORMATION; ANTIBODY SPECIFICITY; BLOOD TRANSFUSION; DUFFY BLOOD-GROUP SYSTEM; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; ISOANTIBODIES; MICE; MICE, TRANSGENIC;

EID: 33748935784     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2006.00966.x     Document Type: Article

References (16)

1. Shirey RS, King KE. Alloimmunization to red cell antigens. In: Anderson K, Ness PM, editors. Scientific basis of transfusion medicine: implications for clinical practice. Philadelphia: Saunders; 2000. p. 393-400.
2. Sela M. Antigenicity, some molecular aspects. Science 1969;166:1365.
3. Pollack W, Gorman JG, Hager HJ, et al. Antibody-mediated immune suppression to the Rh factor: animal models suggesting mechanism of action. Transfusion 1968;8:134-45.
4. Ness PM, Shirey RS, Weinstein MH, King KE. An animal model for delayed hemolytic transfusion reactions. Transfus Med Rev 2001;15:305-17.
5. Halverson GR, Chaudhuri A, Huang T, et al. Immunization of transgenic mice for production of MoAbs directed at polymorphic blood group antigens. Transfusion 2001;41:1393-6.
6. Sharma A, Okabe J, Birch P, McClellan SB, et al. Reduction in the level of Gal(alpha 1,3)Gal in transgenic mice and pigs by the expression of an alpha(1,2)fucosyltransferase. Proc Natl Acad Sci U S A 1996;93:7190-5.
7. Auffray I, Marfatia S, de Jong K, et al. Glycophorin A dimerization and band 3 interaction during erythroid membrane biogenesis: in vivo studies in human glycophorin A transgenic mice. Blood 2001;97:2872-8.
8. Chaudhuri A, Yuen G, Fang F, Storry J. Development of Duffy transgenic mouse: in vivo expression of human Duffy gene with -33T ->C promoter mutation in non-erythroid tissues. Br J Haematol 2004;127:356-9.
9. Reid ME, Lomas-Francis C. The blood group antigen facts book. San Diego: Academic Press; 1997.
10. Wray DW, Baldwin WM III, Sanfilippo F. IgM and IgG alloantibody responses to MHC class I and II following rat renal allograft rejection: effects of transplantectomy and posttransplantation blood transfusions. Transplantation 1992;53:167.
11. Brecher ME, editor. Technical manual. 14th ed. Bethesda: American Association of Blood Banks; 2002.
12. Hall AM, Cairns LS, Altmann D, Barker R, Urbaniak S. Immune responses and tolerance to the RhD blood group protein in HLA-transgenic mice. Blood 2005;105:2175-9.
13. Semple JW, Speck ER, Cosgrave D, et al. Extreme leukoreduction of major histocompatibility complex class II positive B cells enhances allogeneic platelet immunity. Blood 1999;93:713-20.
14. Miwa T, Zhou L, Hilliard B, et al. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack. Blood 2002;99:3707-16.
15. Manodori A, Kuypers F. Altered red cell turnover in diabetic mice. J Lab Clin Med 2002;140:161-5.
16. Van Putten LM, Croon F. The life span of red cells in the rat and the mouse as determined by labeling with DFP32 in vivo. Blood 1958;13:789-94.